Listing of Sequana Medical on Euronext Brussels
Belgian-based medtech company Sequana Medical NV (ticker symbol: SEQUA) raised €27.5 million in successful Initial Public Offering. Ian Crosbie, CEO of Sequana Medical, opens the trading day in Brussels.
Sequana Medical NV
Sequana Medical NV is a commercial stage medical device company focused on the development of innovative treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders.
Founded in Switzerland in 2006, Sequana has established its new corporate headquarters in Ghent, Belgium, in order to benefit from Belgium’s attractive healthcare ecosystem and ultimately to list on Euronext Brussels, one of the most dynamic stock exchanges in Europe for life sciences IPOs.
For more information : sequanamedical.com